Global PD-L1 and PIK3CA Testing Market Research Report 2025(Status and Outlook)
Description
Report Overview
PD-L1 and PIK3CA testing are critical diagnostic tools in precision oncology, used to guide treatment decisions for cancer patients. PD-L1 (Programmed Death-Ligand 1) testing evaluates the expression of the PD-L1 protein on tumor cells, helping identify patients who may benefit from immune checkpoint inhibitors such as pembrolizumab or nivolumab, which enhance the immune system's ability to attack cancer. PIK3CA testing, on the other hand, detects mutations in the PIK3CA gene, which encodes a subunit of the PI3K enzyme involved in cell growth and survival; these mutations are common in cancers like breast, colorectal, and endometrial cancers and can inform the use of targeted therapies such as alpelisib. The market for these tests is driven by the increasing adoption of personalized medicine, rising cancer incidence, and advancements in companion diagnostics. Growth is further supported by regulatory approvals for biomarker-driven therapies and the expansion of next-generation sequencing (NGS) technologies, which enable efficient and comprehensive genomic profiling. However, challenges such as reimbursement complexities, variability in testing methodologies, and the need for standardization may hinder market penetration. Key players include diagnostic companies like Roche, Thermo Fisher Scientific, and Illumina, as well as pharmaceutical firms developing targeted therapies. Emerging markets in Asia-Pacific and Latin America present significant growth opportunities due to improving healthcare infrastructure and increasing awareness of precision oncology. The competitive landscape is characterized by partnerships between diagnostic and pharmaceutical companies to co-develop companion diagnostics, ensuring alignment with therapeutic advancements. As biomarker-driven therapies continue to evolve, demand for PD-L1 and PIK3CA testing is expected to rise, reinforcing their importance in optimizing cancer treatment strategies.
The global PD-L1 and PIK3CA Testing market size was estimated at USD 2333.36 million in 2024, exhibiting a CAGR of 8.75% during the forecast period.
This report provides a deep insight into the global PD-L1 and PIK3CA Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-L1 and PIK3CA Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-L1 and PIK3CA Testing market in any manner.
Global PD-L1 and PIK3CA Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Market Segmentation (by Type)
PD-L1 Testing
PIK3CA Testing
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-L1 and PIK3CA Testing Market
Overview of the regional outlook of the PD-L1 and PIK3CA Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 and PIK3CA Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PD-L1 and PIK3CA Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
PD-L1 and PIK3CA testing are critical diagnostic tools in precision oncology, used to guide treatment decisions for cancer patients. PD-L1 (Programmed Death-Ligand 1) testing evaluates the expression of the PD-L1 protein on tumor cells, helping identify patients who may benefit from immune checkpoint inhibitors such as pembrolizumab or nivolumab, which enhance the immune system's ability to attack cancer. PIK3CA testing, on the other hand, detects mutations in the PIK3CA gene, which encodes a subunit of the PI3K enzyme involved in cell growth and survival; these mutations are common in cancers like breast, colorectal, and endometrial cancers and can inform the use of targeted therapies such as alpelisib. The market for these tests is driven by the increasing adoption of personalized medicine, rising cancer incidence, and advancements in companion diagnostics. Growth is further supported by regulatory approvals for biomarker-driven therapies and the expansion of next-generation sequencing (NGS) technologies, which enable efficient and comprehensive genomic profiling. However, challenges such as reimbursement complexities, variability in testing methodologies, and the need for standardization may hinder market penetration. Key players include diagnostic companies like Roche, Thermo Fisher Scientific, and Illumina, as well as pharmaceutical firms developing targeted therapies. Emerging markets in Asia-Pacific and Latin America present significant growth opportunities due to improving healthcare infrastructure and increasing awareness of precision oncology. The competitive landscape is characterized by partnerships between diagnostic and pharmaceutical companies to co-develop companion diagnostics, ensuring alignment with therapeutic advancements. As biomarker-driven therapies continue to evolve, demand for PD-L1 and PIK3CA testing is expected to rise, reinforcing their importance in optimizing cancer treatment strategies.
The global PD-L1 and PIK3CA Testing market size was estimated at USD 2333.36 million in 2024, exhibiting a CAGR of 8.75% during the forecast period.
This report provides a deep insight into the global PD-L1 and PIK3CA Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-L1 and PIK3CA Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-L1 and PIK3CA Testing market in any manner.
Global PD-L1 and PIK3CA Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Market Segmentation (by Type)
PD-L1 Testing
PIK3CA Testing
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-L1 and PIK3CA Testing Market
Overview of the regional outlook of the PD-L1 and PIK3CA Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 and PIK3CA Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PD-L1 and PIK3CA Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
96 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of PD-L1 and PIK3CA Testing
- 1.2 Key Market Segments
- 1.2.1 PD-L1 and PIK3CA Testing Segment by Type
- 1.2.2 PD-L1 and PIK3CA Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 PD-L1 and PIK3CA Testing Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 PD-L1 and PIK3CA Testing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global PD-L1 and PIK3CA Testing Product Life Cycle
- 3.3 Global PD-L1 and PIK3CA Testing Revenue Market Share by Company (2020-2025)
- 3.4 PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.5 PD-L1 and PIK3CA Testing Company Headquarters, Area Served, Product Type
- 3.6 PD-L1 and PIK3CA Testing Market Competitive Situation and Trends
- 3.6.1 PD-L1 and PIK3CA Testing Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest PD-L1 and PIK3CA Testing Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 PD-L1 and PIK3CA Testing Value Chain Analysis
- 4.1 PD-L1 and PIK3CA Testing Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of PD-L1 and PIK3CA Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global PD-L1 and PIK3CA Testing Market Porter's Five Forces Analysis
- 6 PD-L1 and PIK3CA Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global PD-L1 and PIK3CA Testing Market Size Market Share by Type (2020-2025)
- 6.3 Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (2021-2025)
- 7 PD-L1 and PIK3CA Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global PD-L1 and PIK3CA Testing Market Size (M USD) by Application (2020-2025)
- 7.3 Global PD-L1 and PIK3CA Testing Sales Growth Rate by Application (2020-2025)
- 8 PD-L1 and PIK3CA Testing Market Segmentation by Region
- 8.1 Global PD-L1 and PIK3CA Testing Market Size by Region
- 8.1.1 Global PD-L1 and PIK3CA Testing Market Size by Region
- 8.1.2 Global PD-L1 and PIK3CA Testing Market Size Market Share by Region
- 8.2 North America
- 8.2.1 North America PD-L1 and PIK3CA Testing Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe PD-L1 and PIK3CA Testing Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific PD-L1 and PIK3CA Testing Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America PD-L1 and PIK3CA Testing Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa PD-L1 and PIK3CA Testing Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Agilent Technologies
- 9.1.1 Agilent Technologies Basic Information
- 9.1.2 Agilent Technologies PD-L1 and PIK3CA Testing Product Overview
- 9.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Market Performance
- 9.1.4 Agilent Technologies SWOT Analysis
- 9.1.5 Agilent Technologies Business Overview
- 9.1.6 Agilent Technologies Recent Developments
- 9.2 Roche
- 9.2.1 Roche Basic Information
- 9.2.2 Roche PD-L1 and PIK3CA Testing Product Overview
- 9.2.3 Roche PD-L1 and PIK3CA Testing Product Market Performance
- 9.2.4 Roche SWOT Analysis
- 9.2.5 Roche Business Overview
- 9.2.6 Roche Recent Developments
- 9.3 QIAGEN
- 9.3.1 QIAGEN Basic Information
- 9.3.2 QIAGEN PD-L1 and PIK3CA Testing Product Overview
- 9.3.3 QIAGEN PD-L1 and PIK3CA Testing Product Market Performance
- 9.3.4 QIAGEN SWOT Analysis
- 9.3.5 QIAGEN Business Overview
- 9.3.6 QIAGEN Recent Developments
- 9.4 EntroGen
- 9.4.1 EntroGen Basic Information
- 9.4.2 EntroGen PD-L1 and PIK3CA Testing Product Overview
- 9.4.3 EntroGen PD-L1 and PIK3CA Testing Product Market Performance
- 9.4.4 EntroGen Business Overview
- 9.4.5 EntroGen Recent Developments
- 9.5 Amoy Diagnostics
- 9.5.1 Amoy Diagnostics Basic Information
- 9.5.2 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Overview
- 9.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Market Performance
- 9.5.4 Amoy Diagnostics Business Overview
- 9.5.5 Amoy Diagnostics Recent Developments
- 9.6 ACCB Biotech
- 9.6.1 ACCB Biotech Basic Information
- 9.6.2 ACCB Biotech PD-L1 and PIK3CA Testing Product Overview
- 9.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Market Performance
- 9.6.4 ACCB Biotech Business Overview
- 9.6.5 ACCB Biotech Recent Developments
- 10 PD-L1 and PIK3CA Testing Market Forecast by Region
- 10.1 Global PD-L1 and PIK3CA Testing Market Size Forecast
- 10.2 Global PD-L1 and PIK3CA Testing Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe PD-L1 and PIK3CA Testing Market Size Forecast by Country
- 10.2.3 Asia Pacific PD-L1 and PIK3CA Testing Market Size Forecast by Region
- 10.2.4 South America PD-L1 and PIK3CA Testing Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Sales of PD-L1 and PIK3CA Testing by Country
- 11 Forecast Market by Type and by Application (2026-2033)
- 11.1 Global PD-L1 and PIK3CA Testing Market Forecast by Type (2026-2033)
- 11.2 Global PD-L1 and PIK3CA Testing Market Forecast by Application (2026-2033)
- 12 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
